Gemtaz Infusmart 1.2gm Injection is a vital medication used in the treatment of various cancers. Its active ingredient, Gemcitabine, is a nucleoside analogue that works by interfering with DNA synthesis and repair, ultimately leading to the death of cancer cells. Gemcitabine is commonly prescribed for the treatment of pancreatic cancer, non-small cell lung cancer, breast cancer, and ovarian cancer, often as part of a combination chemotherapy regimen.
The dosage and administration of Gemtaz Infusmart 1.2gm Injection are determined by a qualified healthcare professional based on the specific type and stage of cancer, as well as the patient’s overall health and response to treatment. It is typically administered intravenously. Common side effects may include fatigue, nausea, vomiting, fever, low blood cell counts (leading to increased risk of infection and bleeding), and hair loss. Less common but serious side effects can occur, and patients should report any unusual symptoms to their doctor immediately.
Gemtaz Infusmart 1.2gm Injection should be stored at room temperature, protected from light, and kept out of reach of children. It is crucial to follow the prescribed treatment plan and attend all scheduled appointments for monitoring and evaluation.
